Interactions of mammalian proteins with cisplatin-damaged DNA

John Turchi, Karen M. Henkels, Ingrid L. Hermanson, Steve M. Patrick

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We have undertaken the systematic isolation and characterization of mammalian proteins which display an affinity for cisplatin-damaged DNA. Fractionation of human cell extracts has led to the identification of two classes of proteins. The first includes proteins that bind duplex DNA in the absence of cisplatin damage and retain their affinity for DNA in the presence of cisplatin-DNA adducts. The DNA-dependent protein kinase (DNA-PK) falls into this class. The inhibition of DNA-PK phosphorylation activity by cisplatin-damaged DNA has led to the hypothesis that cisplatin sensitization of mammalian cells to ionizing radiation may be mediated by DNA-PK. The second class of proteins identified are those which display a high relative affinity for cisplatin-damaged DNA and a low affinity for undamaged duplex DNA. Proteins that fall into this class include high mobility group 1 protein (HMG-1), replication protein A (RPA) and xeroderma pigmentosum group A protein (XPA). Each protein has been isolated and purified in the lab. The interaction of each protein with cisplatin-damaged DNA has been assessed in electrophoretic mobility shift assays. A series of DNA binding experiments suggests that RPA binds duplex DNA via denaturation and subsequent preferential binding to the undamaged DNA strand of the partial duplex. DNA substrates prepared with photo-reactive base analogs on either the damaged or undamaged DNA strand have also been employed to investigate the mechanism and specific protein-DNA interactions that occur as each protein binds to cisplatin-damaged DNA. Results suggest both damage and strand specificity for RPA and XPA binding cisplatin-damaged DNA. (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)83-87
Number of pages5
JournalJournal of Inorganic Biochemistry
Volume77
Issue number1-2
DOIs
StatePublished - Oct 1 1999
Externally publishedYes

Fingerprint

Cisplatin
DNA
Proteins
Replication Protein A
DNA-Activated Protein Kinase
Xeroderma Pigmentosum Group A Protein
High Mobility Group Proteins
Cells
Nucleic Acid Denaturation
Electrophoretic mobility
Phosphorylation
Denaturation
Electrophoretic Mobility Shift Assay
Ionizing radiation
Ionizing Radiation
Cell Extracts
Fractionation
Assays

Keywords

  • Cisplatin-damaged DNA
  • DNA
  • Mammalian proteins

ASJC Scopus subject areas

  • Biochemistry
  • Inorganic Chemistry

Cite this

Interactions of mammalian proteins with cisplatin-damaged DNA. / Turchi, John; Henkels, Karen M.; Hermanson, Ingrid L.; Patrick, Steve M.

In: Journal of Inorganic Biochemistry, Vol. 77, No. 1-2, 01.10.1999, p. 83-87.

Research output: Contribution to journalArticle

Turchi, John ; Henkels, Karen M. ; Hermanson, Ingrid L. ; Patrick, Steve M. / Interactions of mammalian proteins with cisplatin-damaged DNA. In: Journal of Inorganic Biochemistry. 1999 ; Vol. 77, No. 1-2. pp. 83-87.
@article{4a50f9cc1811420abd5150f2cbd1d660,
title = "Interactions of mammalian proteins with cisplatin-damaged DNA",
abstract = "We have undertaken the systematic isolation and characterization of mammalian proteins which display an affinity for cisplatin-damaged DNA. Fractionation of human cell extracts has led to the identification of two classes of proteins. The first includes proteins that bind duplex DNA in the absence of cisplatin damage and retain their affinity for DNA in the presence of cisplatin-DNA adducts. The DNA-dependent protein kinase (DNA-PK) falls into this class. The inhibition of DNA-PK phosphorylation activity by cisplatin-damaged DNA has led to the hypothesis that cisplatin sensitization of mammalian cells to ionizing radiation may be mediated by DNA-PK. The second class of proteins identified are those which display a high relative affinity for cisplatin-damaged DNA and a low affinity for undamaged duplex DNA. Proteins that fall into this class include high mobility group 1 protein (HMG-1), replication protein A (RPA) and xeroderma pigmentosum group A protein (XPA). Each protein has been isolated and purified in the lab. The interaction of each protein with cisplatin-damaged DNA has been assessed in electrophoretic mobility shift assays. A series of DNA binding experiments suggests that RPA binds duplex DNA via denaturation and subsequent preferential binding to the undamaged DNA strand of the partial duplex. DNA substrates prepared with photo-reactive base analogs on either the damaged or undamaged DNA strand have also been employed to investigate the mechanism and specific protein-DNA interactions that occur as each protein binds to cisplatin-damaged DNA. Results suggest both damage and strand specificity for RPA and XPA binding cisplatin-damaged DNA. (C) 2000 Elsevier Science Inc.",
keywords = "Cisplatin-damaged DNA, DNA, Mammalian proteins",
author = "John Turchi and Henkels, {Karen M.} and Hermanson, {Ingrid L.} and Patrick, {Steve M.}",
year = "1999",
month = "10",
day = "1",
doi = "10.1016/S0162-0134(99)00145-2",
language = "English (US)",
volume = "77",
pages = "83--87",
journal = "Journal of Inorganic Biochemistry",
issn = "0162-0134",
publisher = "Elsevier Inc.",
number = "1-2",

}

TY - JOUR

T1 - Interactions of mammalian proteins with cisplatin-damaged DNA

AU - Turchi, John

AU - Henkels, Karen M.

AU - Hermanson, Ingrid L.

AU - Patrick, Steve M.

PY - 1999/10/1

Y1 - 1999/10/1

N2 - We have undertaken the systematic isolation and characterization of mammalian proteins which display an affinity for cisplatin-damaged DNA. Fractionation of human cell extracts has led to the identification of two classes of proteins. The first includes proteins that bind duplex DNA in the absence of cisplatin damage and retain their affinity for DNA in the presence of cisplatin-DNA adducts. The DNA-dependent protein kinase (DNA-PK) falls into this class. The inhibition of DNA-PK phosphorylation activity by cisplatin-damaged DNA has led to the hypothesis that cisplatin sensitization of mammalian cells to ionizing radiation may be mediated by DNA-PK. The second class of proteins identified are those which display a high relative affinity for cisplatin-damaged DNA and a low affinity for undamaged duplex DNA. Proteins that fall into this class include high mobility group 1 protein (HMG-1), replication protein A (RPA) and xeroderma pigmentosum group A protein (XPA). Each protein has been isolated and purified in the lab. The interaction of each protein with cisplatin-damaged DNA has been assessed in electrophoretic mobility shift assays. A series of DNA binding experiments suggests that RPA binds duplex DNA via denaturation and subsequent preferential binding to the undamaged DNA strand of the partial duplex. DNA substrates prepared with photo-reactive base analogs on either the damaged or undamaged DNA strand have also been employed to investigate the mechanism and specific protein-DNA interactions that occur as each protein binds to cisplatin-damaged DNA. Results suggest both damage and strand specificity for RPA and XPA binding cisplatin-damaged DNA. (C) 2000 Elsevier Science Inc.

AB - We have undertaken the systematic isolation and characterization of mammalian proteins which display an affinity for cisplatin-damaged DNA. Fractionation of human cell extracts has led to the identification of two classes of proteins. The first includes proteins that bind duplex DNA in the absence of cisplatin damage and retain their affinity for DNA in the presence of cisplatin-DNA adducts. The DNA-dependent protein kinase (DNA-PK) falls into this class. The inhibition of DNA-PK phosphorylation activity by cisplatin-damaged DNA has led to the hypothesis that cisplatin sensitization of mammalian cells to ionizing radiation may be mediated by DNA-PK. The second class of proteins identified are those which display a high relative affinity for cisplatin-damaged DNA and a low affinity for undamaged duplex DNA. Proteins that fall into this class include high mobility group 1 protein (HMG-1), replication protein A (RPA) and xeroderma pigmentosum group A protein (XPA). Each protein has been isolated and purified in the lab. The interaction of each protein with cisplatin-damaged DNA has been assessed in electrophoretic mobility shift assays. A series of DNA binding experiments suggests that RPA binds duplex DNA via denaturation and subsequent preferential binding to the undamaged DNA strand of the partial duplex. DNA substrates prepared with photo-reactive base analogs on either the damaged or undamaged DNA strand have also been employed to investigate the mechanism and specific protein-DNA interactions that occur as each protein binds to cisplatin-damaged DNA. Results suggest both damage and strand specificity for RPA and XPA binding cisplatin-damaged DNA. (C) 2000 Elsevier Science Inc.

KW - Cisplatin-damaged DNA

KW - DNA

KW - Mammalian proteins

UR - http://www.scopus.com/inward/record.url?scp=0033383444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033383444&partnerID=8YFLogxK

U2 - 10.1016/S0162-0134(99)00145-2

DO - 10.1016/S0162-0134(99)00145-2

M3 - Article

VL - 77

SP - 83

EP - 87

JO - Journal of Inorganic Biochemistry

JF - Journal of Inorganic Biochemistry

SN - 0162-0134

IS - 1-2

ER -